Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 447,500
+3,000 (0.67%)
Jan 20, 2026, 11:20 AM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 5.64 trillion as of January 16, 2026. Its market cap has increased by 64.33% in one year.
Market Cap
5.64T
Enterprise Value
6.01T
Revenue
1.47T
Ranking
n/a
PE Ratio
48.39
Stock Price
447,500.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 5.64T, an increase of 728.03%. That is a compound annual growth rate of 14.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 5.53T | -3.43% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |